WallStreetZenWallStreetZen

NASDAQ: OMER
Omeros Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their OMER stock forecasts and price targets.

Forecast return on equity

Is OMER forecast to generate an efficient return?
Company
-63.36%
Industry
47.27%
Market
33.29%
OMER's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OMER forecast to generate an efficient return on assets?
Company
10.33%
Industry
13.28%
OMER is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OMER earnings per share forecast

What is OMER's earnings per share in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.81

OMER vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OMER$4.27N/AN/A
IPSC$2.98$15.67+425.74%Strong Buy
DSGN$4.36$7.00+60.55%Buy
CBUS$9.94$25.00+151.51%Buy
ZVRA$5.85$15.00+156.41%Buy

Omeros Stock Forecast FAQ

What is OMER's earnings growth forecast for 2024-2024?

(NASDAQ: OMER) Omeros's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 20.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.88%.

Omeros's earnings in 2024 is -$121,296,000.

In 2024, OMER is forecast to generate -$104,878,928 in earnings, with the lowest earnings forecast at -$104,878,928 and the highest earnings forecast at -$104,878,928.

If you're new to stock investing, here's how to buy Omeros stock.

What is OMER's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: OMER) forecast ROE is -63.36%, which is considered weak.

What is OMER's Earnings Per Share (EPS) forecast for 2024-2024?

(NASDAQ: OMER) Omeros's current Earnings Per Share (EPS) is -$1.97. In 2024, OMER's EPS is forecast to hit -$1.81 (min: -$1.81, max: -$1.81).

What is OMER's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: OMER) forecast ROA is 10.33%, which is lower than the forecast US Biotechnology industry average of 13.28%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.